High-fat diet, obesity and prostate disease: the ATX-LPA axis?
Kulkarni
Prakash
P
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Getzenberg
Robert H
RH
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000473:pathology; D004041:Dietary Fats / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008246:Lysophospholipids / Q000502:physiology*; D008297:Male; D009097:Multienzyme Complexes / Q000502:physiology*; D009765:Obesity / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D043264:Phosphodiesterase I / Q000502:physiology*; D010727:Phosphoric Diester Hydrolases; D011469:Prostatic Diseases / Q000378:metabolism* / Q000473:pathology; D011755:Pyrophosphatases / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D015854:Up-Regulation / Q000502:physiology; D000099189:Lysophospholipase D
D004041:Dietary Fats; D008246:Lysophospholipids; D009097:Multienzyme Complexes; D043264:Phosphodiesterase I; D010727:Phosphoric Diester Hydrolases; D011755:Pyrophosphatases; D000099189:Lysophospholipase D; C032881:lysophosphatidic acid